Effect of Aromathrapy on Anxiety and Severity of Fatigue
- Conditions
- ?Acute Myocardial Infarecthion.Myocarditis in diseases classified elsewhere
- Registration Number
- IRCT2017011824080N10
- Lead Sponsor
- orestan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
age 18-60 years old; a definite diagnosis of acute heart attack by a physician, and her EC endorsing a heart attack; DNR heart; lung at admission; no history of allergic rhinitis, eczema or respiratory problems such as asthma or chronic obstructive pulmonary disease known; Lack of sense of smell and taste disorders. Lack of medical disorders or uncontrolled contagious. being aware of the time and place and people. Lack of mental illness known. with no history of head injury or seizures. along with a disturbing lack of sleep disorders such as migraine, rheumatoid arthritis, breathing problems at night. having a drug addiction. stable vital signs. having no pain at the time of interview and questionnaire. insensitivity to smell the fragrances; score of more than 20% of Anxiety Inventory (STAI) and the fatigue score between 20 -100 questionnaire MFI-20. Exclusion criteria: the patient's unwillingness to continue the study; cardiogenic shock, cardiac arrest; lung and heart attack this time intervention; a decreased level of consciousness during intervention; the risk of heart rhythm, ventricular fibrillation and cardiogenic shock during the intervention; The use of benzodiazepines, analgesics and anti-anxiety for at least ten hours before the intervention and after the intervention; The use of complementary medicine Sayrdrman for at least a week before the intervention; The incidence of allergic and respiratory dysrhythmias and problems the intervention hemodynamically unstable time intervention patient died before the completion of the study
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anexity. Timepoint: Half an hour before and 15 minutes after intervention, twice a day. Method of measurement: Questionnaire using the Spielberger.;Fatigue. Timepoint: Half an hour before and half an hour after treatment, twice a day. Method of measurement: Using the questionnaire fatigue Mfi.
- Secondary Outcome Measures
Name Time Method Headache. Timepoint: An hour after intervention. Method of measurement: Ask the patient.